Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Oral Baclofen in Pediatric Cerebral Palsy
NCT00607542Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Nov 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of baclofen in spasticity, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoints: Pharmacokinetic parameters of oral baclofen at 1 year, Relationship between plasma concentrations and clinical measures of spasticity at 1 year and 1 more. Started Nov 2008; status: completed.
02
Drugs
baclofen
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT00607542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607542.